ORPEA Announces the Results of Its Share Capital Increase With Shareholders’ Preferential Subscription Rights for an Amount of Approximately EUR 3.9 Billion Backstopped by the Unsecured Creditors of the Company... - Seite 4

AVAILABILITY OF THE PROSPECTUS

The prospectus (the « Prospectus ») approved by the AMF under number 23-465 on November 10^th, 2023 and comprised of (i) ORPEA S.A. 2022 universal registration document filed with the AMF on June 7^th, 2023 under number D. 23-0461 (the “Universal Registration Document” or “URD”), (ii) an amendment to the URD filed with the AMF on November 10^th, 2023 under number D.23-0461-A01 (the “Amendment to the URD”), (iii) the securities note dated November 10^th, 2023 (the “Securities Note”) and (iv) the summary of the Prospectus (included in the Securities Note) is available on the websites of the AMF (www.amf-france.org) and the Company (www.orpea-group.com). Copies of the Prospectus are available free of charge at the Company’s registered office (12, rue Jean Jaurès, 92813 Puteaux).

RISK FACTORS

Investors’ attention is drawn to the risk factors relating to the Company included in chapter 2 « Internal Control and Risk Factors » of the URD as updated in chapter 2 of the Amendment to the URD and the risk factors relating to the transaction and the New Shares mentioned in chapter 2 “Risk Factors” of the Securities Note, in particular risk factor 2.1 related to the massive dilution implied by the Capital Increases and the need for Existing Shareholders to invest significant amounts if they want to maintain their stakes unchanged.

About ORPEA

ORPEA is a leading global player, expert in providing care for all types of frailty. The Group operates in 20 countries and covers three core businesses: care for the elderly (nursing homes, assisted living facilities, homecare and services), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 76,000 employees and welcomes more than 267,000 patients and residents each year.

https ://www.orpea-group.com/

ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a member of the SBF 120, MSCI Small Cap Europe and CAC Mid 60 indices

Disclaimer

This press release does not constitute an offer to sell nor a solicitation of an offer to buy, nor shall there be any sale of ordinary shares in any State or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.